Musumeci, Francesca <br/><br/>
Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors.  [electronic resource] 

 -  Expert opinion on therapeutic patents  Dec 2017 
 - 1305-1318 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7674 
<br/><br/><label>Standard No.: </label>10.1080/13543776.2017.1355908  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Agammaglobulinaemia Tyrosine Kinase<br/>Animals<br/>Autoimmune Diseases--drug therapy<br/>Drug Design<br/>Humans<br/>Leukemia, B-Cell--drug therapy<br/>Lymphoma, B-Cell--drug therapy<br/>Patents as Topic<br/>Protein Kinase Inhibitors--chemistry<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrimidines--chemistry<br/>Pyrroles--chemistry